In publicly available RNA-seq data, a correlation in immune cancer between TIM-3 and CEACAM1 expression is seen, which is consistent with reports by other groups that have shown an overexpression of both TIM-3 and CEACAM1 on tumor-infiltrating T cells in a variety of different tumors (29). This evidence concerns the gene HAVCR2 and neoplasm.